There was also a concomitant decrease (2.5 fold) in mRNA transcript of CTNNB1 and other elements of Wnt/β-catenin signaling (e.g. axin, DVL1, GSK3β) in cancer cells compared to normal cells (Table S1). This evidence concerns the gene CTNNB1 and cancer.